The study titled "The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial" (Diabetes Care, 2003, PMID: 12610036) is a randomized controlled trial investigating the effects of alpha-lipoic acid (ALA) on diabetic polyneuropathy. Involving 120 patients with type 2 diabetes and symptomatic polyneuropathy, participants received either
